The BA.5 strain—a subvariant of omicron—accounted for more than half of all U.S. coronavirus cases last week, as federal regulators encourage drugmakers to retool their vaccines to target new virus strains this fall.
The BA.5 strain—a subvariant of omicron—accounted for more than half of all U.S. coronavirus cases last week, as federal regulators encourage drugmakers to retool their vaccines to target new virus strains this fall.